The Role of the Oncology Nurse Navigator in Establishing an Epic Workflow for Virtual Multidisciplinary Clinics During COVID Restrictions

November 2020 Vol 11, No 11
Laura Beaupre, RN, BSN, OCN, CN-BN
Lehigh Valley Health Network
Allentown, PA
Kathleen Sevedge, RN, MA, AOCN
Lehigh Valley Health Network
Allentown, PA
Angela Miller, RN, BSN, OCN, MEd
Lehigh Valley Health Network
Allentown, PA
Alyssa Pauls, RN, BSN, OCN
Lehigh Valley Health Network
Allentown, PA
Jane Zubia, RN, OCN, CN-BN
Lehigh Valley Health Network,
Allentown, PA
Raizalie Roman, RN, BSN, OCN
Lehigh Valley Health Network,
Allentown, PA
Maritza Chicas, RN, BSN, OCN
Lehigh Valley Health Network
Allentown, PA
Cynthia Smith, RN, BSN, OCN, MA
Lehigh Valley Health Network
Allentown, PA
Tracy Walczer, RN, BSN, OCN
Lehigh Valley Health Network
Allentown, PA
Jeanne Kenna, RN, OCN, CRNI
Lehigh Valley Health Network
Allentown, PA
Paul Torreson
Lehigh Valley Health Network,
Allentown, PA
Eileen Steirer
Lehigh Valley Health Network,
Allentown, PA

Background: Oncology nurse navigators and multidisciplinary models of care have been shown to improve outcomes for patients with cancer.1,2 The navigation team at Lehigh Valley Health Network (LVHN) coordinates 16 multidisciplinary clinics (MDCs) monthly covering 6 disease sites. Newly diagnosed patients attend the clinic to meet their treating team, receive a care plan, and schedule follow-up appointments as appropriate. On March 6, 2020, the Secretary of Health and Human Services modified the 1135 Waiver, allowing Medicare to pay for office, hospital, and other visits furnished via telehealth, including patients’ residence.3 On March 23, Pennsylvania issued stay-at-home orders due to COVID-19.4 Navigators needed to develop alternatives for MDCs to meet the patients’ needs while minimizing face-to-face encounters and maintaining safety. The challenge for the navigators: how to create and organize telehealth visits for multiple providers in the MDC setting?

Objective: To create safe options to hold MDCs remotely, maintaining the same level of quality, during a time when at least half of the providers and navigators were working remotely during COVID restrictions.

Method: Setting up virtual MDC visits required the navigation team to assure Webex access for themselves, providers, and patients; educate providers; work with IT specialists and clerical supervisor to assure accurate scheduling, billing, and documentation; teach the MDC teams the new process; facilitate remote visits; and assure proper sign-off. Navigator super users and IT/Epic specialists determined they could change a scheduled multidisciplinary visit to a video or billable phone visit prior to appointment time. This put the appointment on all providers’ schedules and enabled connection to the patient portal. Navigators educated patients and providers on how to link to the visit if they were off-site.

Using the new scheduling process, navigators coordinated Webex meetings for the team to discuss the plan of care prior to the visit, and the patient joined through the patient portal at the appointed time. One provider led the video or phone visit, using the input from the team, and other providers were able to document in the same encounter within 24 hours. The navigator then ensured that subsequent testing and appointments were scheduled. For patients who were not appropriate or did not want an MDC, navigators facilitated an office visit.

Results: Average pre-COVID monthly MDC volume was 40. After the stay-at-home order, MDCs were put on hold, and the remote option plan was put in place. MDCs began again in April with 4 total visits, all remote, 2 by video and 2 by phone, and most done with at least 1 provider off-site. In May, there were a total of 9 visits, 4 by phone and 5 in person; in June, 16 visits, 1 by phone and 15 in person.

Conclusion: As MDCs ramped up during the COVID restrictions, the navigation team created a new option to safely connect patients, providers, and ancillary staff. Patients and providers appreciated having the opportunity to continue MDCs safely during COVID restrictions, and the remote MDC visit continues to be an option for patients and providers who are off-site.

References

  1. Munoz R, Farshidpour L, Chaudhary UB, Fathi AH. Multidisciplinary cancer care model: a positive association between oncology nurse navigation and improved outcomes for patients with cancer. Clin J Oncol Nurs. 2018;22:E141-E145.
  2. Strusowski P. A multidisciplinary model for cancer care management. Oncol Nurs Forum. 2006;33:697-700.
  3. Centers for Medicare & Medicaid Services. Coronavirus waivers & flexibilities. www.cms.gov/about-cms/emergency-preparedness-response-operations/current-emergencies/coronavirus-waivers. 2020.
  4. Pennsylvania Government. Governor Wolf and Health Secretary issue ‘stay at home’ orders to 7 counties to mitigate spread of COVID-19. www.governor.pa.gov/newsroom/governor-wolf-and-health-secretary-issue-stay-at-home-or ders-to-7-counties-to-mitigate-spread-of-covid-19. 2020.
Related Articles
Assessment of Side Effects (SEs) Impacting Quality of Life (QOL) in Patients (Pts) Undergoing Treatment (tx) for Advanced Breast Cancer (ABC) in Clinical Practice: A Real-World (RW) Multicountry Survey
November 2022 Vol 13, No 11
To examine how SEs impacting QOL in pts with ABC are perceived.
Intracranial Activity of Tepotinib in Patients with MET Exon 14 (METex14) Skipping Non–Small-Cell Lung Cancer (NSCLC) Enrolled in VISION
November 2022 Vol 13, No 11
To provide analysis of the intracranial activity of tepotinib in patients with METex14 skipping NSCLC with BM from the VISION study to aid oncology nurse navigators who manage this population of patients.
MOMENTUM: Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) in Symptomatic and Anemic Myelofibrosis (MF) Patients Previously Treated with a JAK Inhibitor
November 2022 Vol 13, No 11
MF is a rare bone marrow cancer characterized by fibrosis, abnormal blood cell production, and dysregulated JAK/STAT signaling.1,2
Last modified: August 10, 2023

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country